RALEIGH, N.C., Oct. 2, 2024 /PRNewswire/ -- Ambetter of North Carolina Inc., a product offered by a Centene Corporation (NYSE: CNC) company, which provides insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace®, will offer a variety of affordable health insurance plans to North Carolinians in 63 counties for plan year 2025. Open enrollment for the Health Insurance Marketplace for North Carolina runs from Nov. 1, 2024, through Jan. 15, 2025. Enroll by Dec. 15 for coverage starting Jan. 1, 2025.
"Ambetter is excited to continue to expand in North Carolina where we now offer our high-quality, affordable plans in 63 counties," said Ambetter of North Carolina Inc. Plan President, Catherine Campbell. "Our health plans provide members with access to a large network of local doctors and hospitals. We are also pleased to announce an expanded partnership with the YMCA, offering gym memberships and YMCA360 online classes for members beginning October 2024."
Ambetter of North Carolina offers its members access to quality care, convenient services and valuable rewards. The 2025 benefits and extra offerings include:
Below is the full list of counties in which Ambetter of North Carolina Inc. will be offered:
North Carolina residents interested in learning more about Ambetter of North Carolina Inc. or enrolling in a health plan during the open enrollment period may visit ambetterhealth.com/en/nc/.
About Ambetter of North Carolina Inc.
Ambetter of North Carolina Inc. serves under-insured and uninsured populations through the federal Health Insurance Marketplace. Ambetter of North Carolina Inc. is underwritten by Ambetter of North Carolina Inc., which is a Qualified Health Plan issuer in North Carolina. For more information visit ambetterhealth.com/en/nc. This is a solicitation for insurance. For information on your right to receive an Ambetter of North Carolina Inc. plan free of discrimination, or your right to receive language, auditory and/or visual assistance services, please visit ambetterhealth.com/en/ and scroll to the bottom of the page.
Last Trade: | US$54.00 |
Daily Change: | 0.42 0.78 |
Daily Volume: | 3,466,576 |
Market Cap: | US$27.260B |
April 25, 2025 February 24, 2025 February 04, 2025 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load